Cart
0

Ophthalmic Devices Market by Product Function [Ophthalmic Surgery Devices (Refractive Error Surgery Devices, Glaucoma Surgery Devices, Cataract Surgery Devices, and Vitreoretinal Surgery Devices), Ophthalmic Diagnostic Devices (Refractors, Corneal Topography Systems, Retinal Ultrasound Systems, Fundus Camera, Ophthalmoscopes, OCT, Perimeters, Slit Lamps, and Tonometers), Vision Care Devices (Contact Lenses and Spectacles)] - Global Opportunities and Forecasts, 2014-2022

Get 20% Free Customization In This Report
LI_172046
Pages: 216
Apr 2017 | 3312 Views
 
Author's : Deepa Tatkare
Tables: 43
Charts: 81
 

Ophthalmic Devices Market Overview:

Global Ophthalmic Devices Market was valued at $46,029 million in 2015, and is expected to reach $62,113 million by 2022, supported by a CAGR of 4.3% during the forecast period 2014 to 2022. Ophthalmology is a branch of medical sciences that deals with the structure, function, and various eye diseases. The ophthalmic devices are medical equipment designed for diagnosis, surgical, and vision correction purposes. These devices gain increased importance and adoption due to high prevalence of various ophthalmic diseases such as glaucoma, cataract, and other vision related issues. The report analyzes the ophthalmic devices market based on product function and geography.

Global Ophthalmic Devices Market: Segmentation

Global Ophthalmic Devices Market Segmentation

Get more information on this report : Request Sample Pages

Segment Review

According to the AMR analysis, the contact lenses market is expected to grow at a fastest rate in the ophthalmic vision care devices market. This is primarily attributed to a shift in the preference of the users from spectacles toward easy to use contact lenses. The aging population constitutes increase in number of vision related problems, expected to drive the market for contact lenses in the developed as well as the developing nations.

High adoption of digital devices worldwide

The increase in rapid urbanization is parallel to the adoption of digital devices such as computers, smartphones, tablets, laptops, television, game consoles, and e-reader. Continuous long hours spent in front of the screen results into various eye related issues such as eye strain, itchy eyes, headaches, blurred vision, or neck pain. The screen of these devices emits artificial blue light which can be harmful and result into AMD. Currently, the use of these devices is on an increase across all age groups.

Digital Devices Usage Statistics, by Age Group

Digital Devices Usage Statistics by Age Group

Get more information on this report : Request Sample Pages

Usage and Impact of Digital Devices on the Vision

Usage and Impact of Digital Devices on the Vision

Get more information on this report : Request Sample Pages

The key players profiled in the report include Novartis AG, Carl Zeiss Meditec AG, Essilor International S.A., HAAG-Streit Holding AG, Johnson & Johnson, Nidek Co., Ltd., Topcon Corporation, Valeant Pharmaceuticals International, Inc., Hoya Corporation, and Ziemer Ophthalmic Systems AG. The other players operating in the industry include Sonomed Escalon, Gulden Ophthalmics, FCI Ophthalmics, Glaukos Corporation, and STAAR Surgical.

Key Benefits

The study provides an in-depth analysis of the global ophthalmic devices market along with the current trends and future estimations to elucidate the imminent investment pockets.
The report provides quantitative analyses of the industry for the period of 2014‐2022 to enable stakeholders to capitalize on the prevailing market opportunities.
Extensive analysis of the global ophthalmic devices market helps understand the adoption of ophthalmic devices for surgical, diagnostic, and vision care applications.
Competitive intelligence highlights the business practices followed by leading market players across various geographies.

Ophthalmic Devices Market Key Segments

The global ophthalmic devices market is segmented based on product function and geography.

By Product function

  • Ophthalmic Surgical Devices
    • Refractive Error Surgical Devices
      • Excimers and Femtosecond Lasers
      • Microkeratomes
    • Glaucoma Surgical Devices
      • Implants and Stents
      • Glaucoma Drainage
      • Glaucoma Laser Devices
    • Cataract Surgery Devices
      • Intraocular Lenses
      • Viscoelastics
      • Phacoemulsification Systems
    • Vitreoretinal Surgical Devices
      • Vitrectomy Machines & Vitrectomy Packs
      • Photocoagulation Lasers
      • Illumination Devices
  • Ophthalmic Diagnostic Devices
    • Refractors
    • Corneal Topography Systems
    • Retinal Ultrasound Systems
    • Fundus Camera
    • Ophthalmoscopes
    • Optical Coherence Tomography Systems
    • Perimeters
    • Slit Lamps
    • Tonometers
  • Ophthalmic Vision Care Devices
    • Contact Lenses
    • Spectacle Lenses

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • South Africa
    • Saudi Arabia
    • Rest of LAMEA
 

Chapter: 1 INTRODUCTION

1.1. REPORT DESCRIPTION

1.1.1. Key benefits for stakeholders
1.1.2. Key market segments

1.2. RESEARCH METHODOLOGY

1.2.1. Secondary research
1.2.2. Primary research
1.2.3. Analyst tools and models

Chapter: 2 EXECUTIVE SUMMARY

2.1. CXO PERSPECTIVE

Chapter: 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top investment pockets
3.2.2. Top winning strategies

3.2.2.1. Competitive intelligence of companies and their strategies

3.3. MARKET SHARE ANALYSIS, 2015
3.4. TOP PLAYER POSITIONING
3.5. MARKET DYNAMICS

3.5.1. Drivers

3.5.1.1. Rising prevalence of eye related diseases worldwide
3.5.1.2. Rapid technological advancements in ophthalmology
3.5.1.3. Increasing focus on customer training and education along with awareness
3.5.1.4. High adoption of digital devices worldwide

3.5.2. Restraints

3.5.2.1. Low awareness about eye related diseases
3.5.2.2. Dearth of skilled professionals

3.5.3. Opportunities

3.5.3.1. Emerging nations - A great opportunity for ophthalmic devices manufacturers
3.5.3.2. Programs and initiatives worldwide to reduce the burden of eye related diseases

3.6. GOVERNMENT REGULATIONS

3.6.1. FDA
3.6.2. CE Mark
3.6.3. Pharmaceuticals and Medical Devices Agency and Ministry of Health, Labor, and Welfare (MHLW)

Chapter: 4 GLOBAL OPTHALMIC DEVICES MARKET, BY PRODUCT FUNCTION

4.1. OVERVIEW

4.1.1. Market size and forecast

4.2. SURGICAL DEVICES

4.2.1. Key market trends
4.2.2. Key growth factors and opportunities
4.2.3. Market size and forecast
4.2.4. Refractive error surgical devices

4.2.4.1. Market size and forecast
4.2.4.2. Excimers and femtosecond lasers

4.2.4.2.1. Market size and forecast

4.2.4.3. Microkeratomes

4.2.4.3.1. Market size and forecast

4.2.5. Glaucoma surgical devices

4.2.5.1. Market size and forecast
4.2.5.2. Implants and stents

4.2.5.2.1. Market size and forecast

4.2.5.3. Glaucoma drainage devices

4.2.5.3.1. Market size and forecast

4.2.5.4. Glaucoma laser devices

4.2.5.4.1. Market size and forecast

4.2.6. Cataract surgical devices

4.2.6.1. Market size and forecast
4.2.6.2. Intraocular lenses

4.2.6.2.1. Market size and forecast

4.2.6.3. Viscoelastics

4.2.6.3.1. Market size and forecast

4.2.6.4. Phacoemulsification systems

4.2.6.4.1. Market size and forecast

4.2.7. Vitreoretinal surgical devices

4.2.7.1. Market size and forecast
4.2.7.2. Vitrectomy machines and vitrectomy packs

4.2.7.2.1. Market size and forecast

4.2.7.3. Photocoagulation lasers

4.2.7.3.1. Market size and forecast

4.2.7.4. Illumination devices

4.2.7.4.1. Market size and forecast

4.3. DIAGNOSTIC DEVICES

4.3.1. Key market trends
4.3.2. Key growth factors and opportunities

4.3.2.1. Market size and forecast

4.3.3. Refractors

4.3.3.1. Market size and forecast

4.3.4. Corneal topography systems

4.3.4.1. Market size and forecast

4.3.5. Retinal ultrasound systems

4.3.5.1. Market size and forecast

4.3.6. Fundus camera

4.3.6.1. Market size and forecast

4.3.7. Ophthalmoscopes

4.3.7.1. Market size and forecast

4.3.8. Optical coherence tomography systems

4.3.8.1. Market size and forecast

4.3.9. Perimeters

4.3.9.1. Market size and forecast

4.3.10. Slit lamps

4.3.10.1. Market size and forecast

4.3.11. Tonometers

4.3.11.1. Market size and forecast

4.4. VISION CARE DEVICES

4.4.1. Key market trends
4.4.2. Key growth factors and opportunities
4.4.3. Market size and forecast
4.4.4. Contact lenses

4.4.4.1. Market size and forecast

4.4.5. Spectacle lenses

4.4.5.1. Market size and forecast

Chapter: 5 GLOBAL OPHTHALMIC DEVICES MARKET, BY REGION

5.1. OVERVIEW

5.1.1. Market size and forecast

5.2. NORTH AMERICA

5.2.1. Key market trends
5.2.2. Growth factors and opportunities
5.2.3. Market size and forecast
5.2.4. U.S. market size and forecast
5.2.5. Canada market size and forecast
5.2.6. Mexico market size and forecast

5.3. EUROPE

5.3.1. Key market trends
5.3.2. Growth factors and opportunities
5.3.3. Market size and forecast
5.3.4. Germany market size and forecast
5.3.5. France market size and forecast
5.3.6. UK market size and forecast
5.3.7. Italy market size and forecast
5.3.8. Spain market size and forecast
5.3.9. Rest of the Europe market size and forecast

5.4. ASIA-PACIFIC

5.4.1. Key market trends
5.4.2. Growth factors and opportunities
5.4.3. Market size and forecast
5.4.4. Japan market size and forecast
5.4.5. China market size and forecast
5.4.6. Australia market size and forecast
5.4.7. India market size and forecast
5.4.8. South Korea market size and forecast
5.4.9. Rest of Asia-Pacific market size and forecast

5.5. LAMEA

5.5.1. Key market trends
5.5.2. Growth factors and opportunities
5.5.3. Market size and forecast
5.5.4. Brazil market size and forecast
5.5.5. Saudi Arabia market size and forecast
5.5.6. South Africa market size and forecast
5.5.7. Rest of LAMEA market size and forecast

Chapter: 6 COMPANY PROFILES

6.1. ALCON, INC.

6.1.1. Company overview
6.1.2. Operating business segments
6.1.3. Business performance
6.1.4. Key strategic moves and developments

6.2. CARL ZEISS MEDITEC AG

6.2.1. Company overview
6.2.2. Operating business segments
6.2.3. Business performance
6.2.4. Key strategic moves & developments

6.3. ESSILOR INTERNATIONAL S.A.

6.3.1. Company overview
6.3.2. Operating business segments
6.3.3. Business performance

6.4. HAAG-STREIT HOLDING AG

6.4.1. Company overview
6.4.2. Operating business segments
6.4.3. Business performance

6.5. HOYA CORPORATION

6.5.1. Company overview
6.5.2. Operating business segments
6.5.3. Business performance
6.5.4. Key strategic moves and developments

6.6. JOHNSON & JOHNSON

6.6.1. Company overview
6.6.2. Operating business segments
6.6.3. Business performance
6.6.4. Key strategic moves and developments

6.7. NIDEK CO., LTD.

6.7.1. Company overview
6.7.2. Operating business segments
6.7.3. Business performance
6.7.4. Key strategic moves & developments

6.8. TOPCON CORPORATION

6.8.1. Company overview
6.8.2. Operating business segments
6.8.3. Business performance
6.8.4. Key strategic moves & developments

6.9. VALEANT PHARMACEUTICALS INTERNATIONAL, INC.

6.9.1. Company overview
6.9.2. Operating business segments
6.9.3. Business performance
6.9.4. Key strategic moves & developments

6.10. ZIEMER OPHTHALMIC SYSTEMS AG

6.10.1. Company overview
6.10.2. Business performance
6.10.3. Key strategic moves & developments

LIST OF TABLES

TABLE 1. GLOBAL VISION IMPAIRMENT BY AGE, 2010
TABLE 2. NUMBER OF OPHTHALMOLOGIST WORLDWIDE, 2010
TABLE 3. PREVALENCE OF DIABETIC RETINOPATHY IN PATIENTS SUFFERING FROM OTHER END-ORGAN DISEASES, 2014
TABLE 4. PREVALENCE OF DIABETIC RETINOPATHY WITH RESPECT TO DURATION OF DIABETES MELLITUS
TABLE 5. GLOBAL OPHTHALMIC DEVICES MARKET, BY PRODUCT FUNCTION, 2014-2022($MILLION)
TABLE 6. GLOBAL OPHTHALMIC SURGICAL DEVICES MARKET, BY TYPE, 2014-2022($MILLION)
TABLE 7. GLOBAL OPHTHALMIC SURGICAL DEVICES MARKET, BY REGION, 2014-2022($MILLION)
TABLE 8. GLOBAL REFRACTIVE ERROR SURGICAL DEVICES MARKET, BY TYPE, 2014-2022($MILLION)
TABLE 9. GLOBAL REFRACTIVE ERROR SURGICAL DEVICES MARKET, BY REGION, 2014-2022($MILLION)
TABLE 10. GLOBAL GLAUCOMA SURGICAL DEVICES MARKET, BY TYPE, 2014-2022($MILLION)
TABLE 11. GLOBAL GLAUCOMA SURGICAL DEVICES MARKET, BY REGION, 2014-2022($MILLION)
TABLE 12. GLOBAL CATARACT SURGERY DEVICES MARKET, BY TYPE, 2014-2022($MILLION)
TABLE 13. GLOBAL CATARACT SURGERY DEVICES MARKET, BY REGION, 2014-2022($MILLION)
TABLE 14. GLOBAL VITREORETINAL SURGICAL DEVICES MARKET, BY TYPE 2014-2022 ($MILLION)
TABLE 15. GLOBAL VITREORETINAL SURGICAL DEVICES MARKET, BY REGION 2014-2022 ($MILLION)
TABLE 16. GLOBAL OPHTHALMIC DIAGNOSTIC DEVICES MARKET, BY TYPE, 2014-2022($MILLION)
TABLE 17. GLOBAL OPHTHALMIC DIAGNOSTIC DEVICES MARKET, BY REGION, 2014-2022($MILLION)
TABLE 18. GLOBAL OPHTHALMIC VISION CARE DEVICES MARKET, BY TYPE, 2014-2022 ($MILLION)
TABLE 19. GLOBAL OPHTHALMIC VISION CARE DEVICES MARKET, BY REGION, 2014-2022 ($MILLION)
TABLE 20. GLOBAL OPHTHALMIC DEVICES MARKET, BY REGION, 2014-2022 ($MILLION)
TABLE 21. NORTH AMERICA OPHTHALMIC DEVICES MARKET, BY COUNTRY, 2014-2022($MILLION)
TABLE 22. EUROPE OPHTHALMIC DEVICES MARKET, BY COUNTRY, 2014-2022 ($MILLION)
TABLE 23. ASIA-PACIFIC OPHTHALMIC DEVICES MARKET, BY COUNTRY, 2014-2022($MILLION)
TABLE 24. LAMEA OPHTHALMIC DEVICES MARKET, BY COUNTRY2014-2022($MILLION)
TABLE 25. ALCON: COMPANY SNAPSHOT
TABLE 26. ALCON: OPERATING SEGMENTS
TABLE 27. CARL ZEISS: COMPANY SNAPSHOT
TABLE 28. CARL ZEISS: OPERATING SEGMENTS
TABLE 29. ESSILOR: COMPANY SNAPSHOT
TABLE 30. ESSILOR: OPERATING SEGMENTS
TABLE 31. HAAG-STREIT: COMPANY SNAPSHOT
TABLE 32. HAAG-STREIT: OPERATING SEGMENTS
TABLE 33. HOYA: COMPANY SNAPSHOT
TABLE 34. HOYA: OPERATING SEGMENTS
TABLE 35. JNJ: COMPANY SNAPSHOT
TABLE 36. JNJ: OPERATING SEGMENTS
TABLE 37. NIDEK: COMPANY SNAPSHOT
TABLE 38. NIDEK: OPERATING SEGMENTS
TABLE 39. TOPCON: COMPANY SNAPSHOT
TABLE 40. TOPCON: OPERATING SEGMENTS
TABLE 41. BAUSCH + LOMB: COMPANY SNAPSHOT
TABLE 42. BAUSCH + LOMB: OPERATING SEGMENTS
TABLE 43. ZEIMER: COMPANY SNAPSHOT

LIST OF FIGURES

FIGURE 1. OPHTHALMIC DEVICES MARKET SEGMENTATION
FIGURE 2. TOP INVESTMENT POCKETS
FIGURE 3. TOP WINNING STRATEGIES: PERCENTAGE DISTRIBUTION, (2014-2016)
FIGURE 4. TOP WINNING STRATEGIES: NATURE AND TYPE
FIGURE 5. TOP COMPANIES AND THEIR STRATEGIES
FIGURE 6. DETAILED STRUCTURE OF COMPANIES AND NATURE OF STRATEGIES
FIGURE 7. DETAILED STRUCTURE OF COMPANIES AND TYPE OF STRATEGIES
FIGURE 8. MARKET SHARE ANALYSIS: OPHTHALMIC SURGICAL DEVICES MARKET, 2015
FIGURE 9. MARKET SHARE ANALYSIS: OPHTHALMIC VISION CARE DEVICES MARKET, 2015
FIGURE 10. TOP PLAYER POSITIONING, 2015
FIGURE 11. MAJOR CAUSES OF VISUAL IMPAIRMENT WORLDWIDE, 2010
FIGURE 12. MAJOR CAUSES OF BLINDNESS WORLDWIDE, 2010
FIGURE 13. GLOBAL IMPAIRMENT BY WHO REGION AND COUNTRY, 2010
FIGURE 14. DIGITAL DEVICES USAGE STATISTICS, BY AGE GROUP
FIGURE 15. USAGE AND IMPACT OF DIGITAL DEVICES ON THE VISION
FIGURE 16. GLOBAL UNDIAGNOSED EYE RELATED DISORDERS, 2010
FIGURE 17. GLOBAL EXCIMERS AND FEMTOSECOND LASERS MARKET, 2014-2022 ($MILLION)
FIGURE 18. GLOBAL MICROTOMES MARKET, 2014-2022 ($MILLION)
FIGURE 19. WORLDWIDE GLAUCOMA PREVALENCE, 2010-2020
FIGURE 20. GLOBAL IMPLANTS AND STENTS MARKET, 2014-2022 ($MILLION)
FIGURE 21. GLOBAL GLAUCOMA DRAINAGE DEVICES MARKET, 2014-2022 ($MILLION)
FIGURE 22. GLOBAL GLAUCOMA LASER DEVICES MARKET ($MILLION), 2014-2022
FIGURE 23. GLOBAL INTRAOCULAR LENSES MARKET, 2014-2022($MILLION)
FIGURE 24. GLOBAL VISCOELASTICS MARKET, 2014-2022($MILLION)
FIGURE 25. GLOBAL PHACOEMULSIFICATION SYSTEMS MARKET, 2014-2022 ($MILLION)
FIGURE 26. GLOBAL VITRECTOMY MACHINES AND VITRECTOMY PACKS MARKET, 2014-2022 ($MILLION)
FIGURE 27. GLOBAL PHOTOCOAGULATION LASERS MARKET, 2014-2022 ($MILLION)
FIGURE 28. GLOBAL ILLUMINATION DEVICES MARKET, 2014-2022 ($MILLION)
FIGURE 29. GLOBAL REFRACTORS MARKET, 2014-2022 ($MILLION)
FIGURE 30. GLOBAL CORNEAL TOPOGRAPHY SYSTEMS MARKET, 2014-2022 ($MILLION)
FIGURE 31. GLOBAL RETINAL ULTRASOUND SYSTEMS MARKET, 2014-2022 ($MILLION)
FIGURE 32. GLOBAL FUNDUS CAMERA MARKET, 2014-2022 ($MILLION)
FIGURE 33. GLOBAL OPHTHALMOSCOPES MARKET, 2014-2022 ($MILLION)
FIGURE 34. GLOBAL OPTICAL COHERANCE TOMPGRAPHY SYSTEMS MARKET, 2014-2022 ($MILLION)
FIGURE 35. GLOBAL PERIMETERS MARKET, 2014-2022 ($MILLION)
FIGURE 36. GLOBAL SLIT LAMPS MARKET, 2014-2022 ($MILLION)
FIGURE 37. GLOBAL TONOMETERS MARKET, 2014-2022 ($MILLION)
FIGURE 38. GLOBAL CONTACT LENSES MARKET, 2014-2022 ($MILLION)
FIGURE 39. GLOBAL SPECTACLE LENSES MARKET, 2014-2022 ($MILLION)
FIGURE 40. GLAUCOMA INCIDENCE IN U.S, 2010-2050
FIGURE 41. U.S. OPHTHALMIC DEVICES MARKET, 2014-2022 ($MILLION)
FIGURE 42. CANADA OPHTHALMICDEVICES MARKET, 2014-2022 ($MILLION)
FIGURE 43. MEXICO OPHTHALMICDEVICES MARKET, 2014-2022 ($MILLION)
FIGURE 44. GROWTH IN THE CATARACT SURGICAL PROCEDURES, DAY CASES AND INPATIENT CASES 2000-2010
FIGURE 45. CATARACT SURGERY PROCEDURES PERFORMED IN EUROPE, BY DEMOGRAPHICS 2012
FIGURE 46. GERMANY OPHTHALMIC DEVICES MARKET, 2014-2022 ($MILLION)
FIGURE 47. FRANCE OPHTHALMIC DEVICES MARKET, 2014-2022 ($MILLION)
FIGURE 48. UK OPHTHALMIC DEVICES MARKET, 2014-2022 ($MILLION)
FIGURE 49. ITALY OPHTHALMIC DEVICES MARKET, 2014-2022 ($MILLION)
FIGURE 50. SPAIN OPHTHALMIC DEVICES MARKET, 2014-2022 ($MILLION)
FIGURE 51. REST OF THE EUROPE OPHTHALMIC DEVICES MARKET, 2014-2022 ($MILLION)
FIGURE 52. LEADING CAUSES OF BLINDNESS IN JAPAN, 2013
FIGURE 53. LEADING CAUSES OF BLINDNESS IN INDIA, 2014
FIGURE 54. JAPAN OPHTHALMICDEVICES MARKET, 2014-2022($MILLION)
FIGURE 55. CHINA OPHTHALMICDEVICES MARKET, 2014-2022 ($MILLION)
FIGURE 56. AUSTRALIA OPHTHALMICDEVICES MARKET, 2014-2022 ($MILLION)
FIGURE 57. INDIA OPHTHALMICDEVICES MARKET, 2014-2022 ($MILLION)
FIGURE 58. SOUTH KOREA OPHTHALMICDEVICES MARKET, 2014-2022 ($MILLION)
FIGURE 59. REST OF ASIA-PACIFIC OPHTHALMICDEVICES MARKET, 2014-2022 ($MILLION)
FIGURE 60. BRAZIL OPHTHALMIC DEVICES MARKET, 2014-2022 ($MILLION)
FIGURE 61. SAUDI ARABIA OPHTHALMICDEVICES MARKET, 2014-2022 ($MILLION)
FIGURE 62. SOUTH AFRICA OPHTHALMICDEVICES MARKET, 2014-2022 ($MILLION)
FIGURE 63. REST OF LAMEA OPHTHALMICDEVICES MARKET, 2014-2022 ($MILLION)
FIGURE 64. ALCON: REVENUE BY YEAR ($MILLION)
FIGURE 65. ALCON: REVENUE BY SEGMENT, 2016 (%)
FIGURE 66. CARL ZEISS: REVENUE BY YEAR ($MILLION)
FIGURE 67. CARL ZEISS: REVENUE BY SEGMENT, 2016 (%)
FIGURE 68. CARL ZEISS: REVENUE BY GEOGRAPHY, 2016 (%)
FIGURE 69. ESSILOR: REVENUE BY YEAR ($MILLION)
FIGURE 70. ESSILOR: REVENUE BY SEGMENT, 2015 (%)
FIGURE 71. ESSILOR: REVENUE BY GEOGRAPHY, 2015 (%)
FIGURE 72. HOYA: REVENUE BY YEAR ($MILLION)
FIGURE 73. HOYA: REVENUE BY SEGMENT, 2015 (%)
FIGURE 74. HOYA: REVENUE BY GEOGRAPHY, 2015 (%)
FIGURE 75. JNJ: REVENUE, BY YEAR ($MILLION) (2013-2015)
FIGURE 76. JNJ: REVENUE, BY SEGMENT, 2015 (%)
FIGURE 77. JNJ: REVENUE, BY REGION, 2015 (%)
FIGURE 78. TOPCON: REVENUE BY YEAR ($MILLION)
FIGURE 79. TOPCON: REVENUE BY SEGMENT, 2015 (%)
FIGURE 80. TOPCON: REVENUE BY GEOGRAPHY, 2015 (%)
FIGURE 81. BAUSCH + LOMB: REVENUE BY YEAR ($MILLION)

 

The global ophthalmic devices market is expected to witness significant growth in the near future, owing to the high prevalence of eye diseases across all age groups (especially the geriatric population) and all geographies. North America is expected to account for the major share of the market throughout the forecast period. This is primarily attributed to the high prevalence of eye related diseases in this region. Asia-Pacific and LAMEA are expected to offer lucrative opportunities to market players in the near future. India and China are expected to be the destination of interest for the major ophthalmic device manufacturers owing to high prevalence of cataract and glaucoma and increase in geriatric population in these countries. In addition, the market experiences a paradigm shift in the recent years, because major players distribute their products in the emerging markets, including China, India, and Brazil.

The growth of the global ophthalmic devices market is attributed to factors such as increase in incidence of various eye related diseases such as cataract, glaucoma, and age-related macular degeneration, rapid adoption of digital devices, and increase in focus on customer training and education. However, dearth of skilled professionals and lack of awareness related to eye diseases are projected to restrain the market growth.

In the present scenario, the vision care devices segment dominates the global ophthalmic devices market owing to growth in prevalence of refractive errors worldwide. For instance, as per the World Health Organization, refractive errors accounted for 43% of the total causes of visual impairment in 2010 globally. Vision care devices thus play a vital role to control the increase in burden of refractive errors since they provide vision correction.

 

PURCHASE OPTIONS

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Reach out to us

Call us on
( U.S. - Canada toll free )
+1-800-792-5285,    Int'l : +1-503-894-6022
Drop us an email at
help@alliedmarketresearch.com

Send Enquiry
 

Request Sample

Request Customization

Request sample

OR

Purchase Full Report of
Ophthalmic Devices Market- Global Opportunities and Forecasts, 2014-2022

  • Online Only
  • $3456 $3111
  • Online cloud Access only
  • Restricted Print, copy, paste,download
  • Read Only
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Data Pack
  • $3840 $3456
  • Restricted to one authorized users
  • One print only
  • Available in Excel
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Single User
  • $5370 $4565
  • Restricted to one authorized users
  • One print only
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Five User
  • $6450 $5160
  • Limited to 5 authorized users
  • Print Upto Five Copies
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Enterprise
    License/PDF

  • $8995 $6747
  • Unlimited within company/enterprise
  • Unlimited within company/enterprise
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 
 

FREQUENTLY ASKED
QUESTIONS?

 
 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 
 
 

Why Allied Market Research

 

Infallible Methodology

To ensure high level data integrity, accurate analysis and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 
 

Featured Reports

 
 

Featured Readings

 

Get Fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

 
Get Industry Data Alerts
 

Access reports on all emerging
market of Life Sciences on Knowledge Tree Platform
Free Demo